fluocinolone acetonide 0.1 MG/ML / hydroquinone 40 MG/ML / tretinoin 0.5 MG/ML Topical Cream [Tri-Luma]
- RxCUI
- 1191264
- RxNorm name
- fluocinolone acetonide 0.1 MG/ML / hydroquinone 40 MG/ML / tretinoin 0.5 MG/ML Topical Cream [Tri-Luma]
- Display name
- TRI-LUMA (Topical)
- Full name
- fluocinolone acetonide 0.1 MG/ML / hydroquinone 40 MG/ML / tretinoin 0.5 MG/ML Topical Cream [Tri-Luma]
- Term type
- SBD
- Status
- Active
- Strength
- 0.01-4-0.05%
- Dose form
- Cream
- Route
- Topical
- Updated
- 2026-06-17 07:06:25
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 112011
- Active start
- 112011
- Multiple ingredient
- YES
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| tretinoin | 0.5 MG / 1 ML | tretinoin | tretinoin |
| fluocinolone acetonide | 0.1 MG / 1 ML | fluocinolone | fluocinolone acetonide |
| hydroquinone | 40 MG / 1 ML | hydroquinone | hydroquinone |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Topical Cream | 316982 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| tretinoin | 10753 |
| fluocinolone | 25126 |
| hydroquinone | 5509 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | Tri-Luma (fluocinolone acetonide 0.01 % / hydroquinone 4 % / tretinoin 0.05 % ) Topical Cream | 1 | NAMES |
| RxNorm Name | fluocinolone acetonide 0.1 MG/ML / hydroquinone 40 MG/ML / tretinoin 0.5 MG/ML Topical Cream [Tri-Luma] | 1 | NAMES |
| RxNorm Synonym | Tri-Luma (fluocinolone acetonide 0.01 % / hydroquinone 4 % / tretinoin 0.05 % ) Topical Cream | 1 | NAMES |
| TTY | SBD | 1 | ATTRIBUTES |
| SPL_SET_ID | a35fa709-5eb5-4429-b38f-f1e0019bf0ee | 1 | CODES |
| RxCUI | 1191264 | 1 | CODES |
| MMSL_CODE | BD8566 | 1 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 0299-5950-02 | 0299-5950 | TRI-LUMA fluocinolone acetonide, hydroquinone, and tretinoin | Galderma Laboratories, L.P. | NDA021112 |
| 0299-5950-30 | 0299-5950 | TRI-LUMA fluocinolone acetonide, hydroquinone, and tretinoin | Galderma Laboratories, L.P. | NDA021112 |
Drugs@FDA Applications#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TRI-LUMA | FLUOCINOLONE ACETONIDE, HYDROQUINONE, AND TRETINOIN | Galderma Laboratories, L.P. | a35fa709-5eb5-4429-b38f-f1e0019bf0ee | 2024-10-24 | Warnings, Adverse reactions | 0299-5950-02 0299-5950-30 0299-5950 00299595002 00299595030 1191264 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| a35fa709-5eb5-4429-b38f-f1e0019bf0ee | Tri-Luma 0.01 % / 4 % / 0.05 % Topical Cream [PSN] · fluocinolone acetonide 0.1 MG/ML / hydroquinone 40 MG/ML / tretinoin 0.5 MG/ML Topical Cream [Tri-Luma] [SBD] · Tri-Luma (fluocinolone acetonide 0.01 % / hydroquinone 4 % / tretinoin 0.05 % ) Topical Cream [SY] | 3 | 18 | These highlights do not include all the information needed to use TRI-LUMA Cream safely and effectively. See full prescribing information for TRI-LUMA Cream. TRI-LUMA ® (fluocinolone acetonide, hydroquinone, tretinoin) cream, 0.01%/4%/0.05% for topical use Initial U.S. Approval: 2002 | 20241024 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| a35fa709-5eb5-4429-b38f-f1e0019bf0ee | These highlights do not include all the information needed to use TRI-LUMA Cream safely and effectively. See full prescribing information for TRI-LUMA Cream. TRI-LUMA ® (fluocinolone acetonide, hydroquinone, tretinoin) cream, 0.01%/4%/0.05% for topical use Initial U.S. Approval: 2002 | Galderma Laboratories, L.P. | Hill Dermaceuticals, Inc. | G Production, Inc. | 20241024 |
| 6f9b70a7-c0fa-4d27-bd5b-9a48f9a6170b | National Council for Prescription Drug Programs | 20120724 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | C05AA | Corticosteroids | ATC1-4 | fluocinolone acetonide | |
| ATC | S02BA | Corticosteroids | ATC1-4 | fluocinolone acetonide | |
| ATC | S01BA | Corticosteroids, plain | ATC1-4 | fluocinolone acetonide | |
| ATC | D07AC | Corticosteroids, potent (group III) | ATC1-4 | fluocinolone acetonide | |
| ATC | D11AX | Other dermatologicals | ATC1-4 | hydroquinone | |
| ATC | L01XF | Retinoids for cancer treatment | ATC1-4 | tretinoin | |
| ATC | D10AD | Retinoids for topical use in acne | ATC1-4 | tretinoin | |
| FDASPL | D012176 | Retinoids | CHEM | has_chemical_structure | tretinoin |
| FDASPL | N0000175576 | Corticosteroid | EPC | has_epc | fluocinolone acetonide |
| FDASPL | N0000175854 | Melanin Synthesis Inhibitor | EPC | has_epc | hydroquinone |
| FDASPL | N0000175607 | Retinoid | EPC | has_epc | tretinoin |
| FDASPL | N0000175450 | Corticosteroid Hormone Receptor Agonists | MOA | has_moa | fluocinolone acetonide |
| FDASPL | N0000175850 | Melanin Synthesis Inhibitors | MOA | has_moa | hydroquinone |
| FDASPL | N0000175851 | Depigmenting Activity | PE | has_pe | hydroquinone |
| MEDRT | D005446 | Fluocinolone Acetonide | CHEM | has_ingredient | fluocinolone acetonide |
| MEDRT | D005446 | Fluocinolone Acetonide | CHEM | has_ingredient | fluocinolone |
| MEDRT | D006873 | Hydroquinones | CHEM | has_ingredient | hydroquinone |
| MEDRT | D010226 | Parabens | CHEM | ci_chemclass | tretinoin |
| MEDRT | D014212 | Tretinoin | CHEM | has_ingredient | tretinoin |
| MEDRT | D000152 | Acne Vulgaris | DISEASE | may_treat | tretinoin |
| MEDRT | D003876 | Dermatitis, Atopic | DISEASE | may_treat | fluocinolone acetonide |
| MEDRT | D003876 | Dermatitis, Atopic | DISEASE | may_treat | fluocinolone |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | tretinoin |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | hydroquinone |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | fluocinolone acetonide |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | fluocinolone |
| MEDRT | D005148 | Facial Dermatoses | DISEASE | may_treat | tretinoin |
| MEDRT | D005148 | Facial Dermatoses | DISEASE | may_treat | fluocinolone acetonide |
| MEDRT | D005148 | Facial Dermatoses | DISEASE | may_treat | fluocinolone |
| MEDRT | D005533 | Foot Dermatoses | DISEASE | may_treat | fluocinolone |
| MEDRT | D005533 | Foot Dermatoses | DISEASE | may_treat | fluocinolone acetonide |
| MEDRT | D006229 | Hand Dermatoses | DISEASE | may_treat | fluocinolone |
| MEDRT | D006229 | Hand Dermatoses | DISEASE | may_treat | fluocinolone acetonide |
| MEDRT | D017495 | Hyperpigmentation | DISEASE | may_treat | hydroquinone |
| MEDRT | D017495 | Hyperpigmentation | DISEASE | may_treat | tretinoin |
| MEDRT | D006967 | Hypersensitivity | DISEASE | ci_with | fluocinolone acetonide |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | fluocinolone |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | fluocinolone acetonide |
| MEDRT | D007868 | Leg Dermatoses | DISEASE | may_treat | fluocinolone acetonide |
| MEDRT | D007868 | Leg Dermatoses | DISEASE | may_treat | fluocinolone |
| MEDRT | D015473 | Leukemia, Promyelocytic, Acute | DISEASE | may_treat | tretinoin |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | tretinoin |
| MEDRT | D011537 | Pruritus | DISEASE | may_treat | fluocinolone acetonide |
| MEDRT | D011537 | Pruritus | DISEASE | may_treat | fluocinolone |
| MEDRT | D011565 | Psoriasis | DISEASE | may_treat | fluocinolone acetonide |
| MEDRT | D011565 | Psoriasis | DISEASE | may_treat | fluocinolone |
| MEDRT | D012536 | Scalp Dermatoses | DISEASE | may_treat | fluocinolone acetonide |
| MEDRT | D013471 | Sunburn | DISEASE | ci_with | hydroquinone |
| MEDRT | N0000000159 | Glucocorticoid Receptor Agonists | MOA | has_moa | fluocinolone acetonide |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | fluocinolone |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | fluocinolone acetonide |
| MEDRT | N0000000085 | Receptor Interactions | MOA | has_moa | tretinoin |
| MEDRT | N0000020001 | Tyrosine Kinase Inhibitors | MOA | has_moa | hydroquinone |
| MEDRT | N0000009915 | Unknown Cellular or Molecular Interaction | MOA | has_moa | tretinoin |
| MEDRT | N0000008297 | Antipruritic Activity | PE | has_pe | fluocinolone acetonide |
| MEDRT | N0000175676 | Decreased Epithelial Proliferation | PE | has_pe | tretinoin |
| MEDRT | N0000008663 | Decreased Immunologically Active Molecule Activity | PE | has_pe | fluocinolone acetonide |
| MEDRT | N0000008663 | Decreased Immunologically Active Molecule Activity | PE | has_pe | fluocinolone |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | fluocinolone acetonide |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | fluocinolone |
| MEDRT | N0000009982 | Decreased Sebaceous Gland Activity | PE | has_pe | tretinoin |
| MEDRT | N0000009979 | Decreased Sebaceous Gland Quantity | PE | has_pe | tretinoin |
| MEDRT | N0000175851 | Depigmenting Activity | PE | has_pe | hydroquinone |
| MEDRT | N0000009908 | Vasoconstriction | PE | has_pe | fluocinolone acetonide |
| MEDRT | N0000009908 | Vasoconstriction | PE | has_pe | fluocinolone |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 0.1 MG/ML / 40 MG/ML / 0.5 MG/ML |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | NDA | NDA021112 |
| NAMES | Prescribable Synonym | Tri-Luma 0.01 % / 4 % / 0.05 % Topical Cream |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |